Technical Analysis for SCNI - Scinai Immunotherapeutics Ltd.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.45 | 0.02% | 0.00 |
SCNI closed up 2.34 percent on Wednesday, May 8, 2024, on 10 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Hammer Candlestick | Bullish | 0.02% | |
MACD Bullish Signal Line Cross | Bullish | 0.02% | |
NR7 | Range Contraction | 0.02% | |
Doji - Bullish? | Reversal | 0.02% | |
Gapped Up | Strength | 0.02% | |
20 DMA Resistance | Bearish | 2.37% | |
MACD Bearish Signal Line Cross | Bearish | 2.37% | |
Gapped Up | Strength | 2.37% | |
Fell Below 20 DMA | Bearish | 0.22% | |
Inside Day | Range Contraction | 0.22% |
Alert | Time |
---|---|
Possible NR7 | about 21 hours ago |
Down 1% | 1 day ago |
Gap Up Closed | 1 day ago |
Gap Up Partially Closed | 1 day ago |
60 Minute Opening Range Breakdown | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2023
Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Disease Contract Manufacturing Organization Autoimmune And Infectious Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Disease Contract Manufacturing Organization Autoimmune And Infectious Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.27 |
52 Week Low | 0.1 |
Average Volume | 28,772 |
200-Day Moving Average | 0.73 |
50-Day Moving Average | 0.48 |
20-Day Moving Average | 0.46 |
10-Day Moving Average | 0.45 |
Average True Range | 0.03 |
RSI (14) | 45.65 |
ADX | 17.2 |
+DI | 8.60 |
-DI | 12.85 |
Chandelier Exit (Long, 3 ATRs) | 0.40 |
Chandelier Exit (Short, 3 ATRs) | 0.53 |
Upper Bollinger Bands | 0.49 |
Lower Bollinger Band | 0.43 |
Percent B (%b) | 0.33 |
BandWidth | 11.71 |
MACD Line | -0.01 |
MACD Signal Line | -0.01 |
MACD Histogram | 0.0001 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.47 | ||||
Resistance 3 (R3) | 0.47 | 0.46 | 0.47 | ||
Resistance 2 (R2) | 0.46 | 0.45 | 0.46 | 0.47 | |
Resistance 1 (R1) | 0.46 | 0.45 | 0.45 | 0.46 | 0.47 |
Pivot Point | 0.44 | 0.44 | 0.44 | 0.45 | 0.44 |
Support 1 (S1) | 0.44 | 0.44 | 0.43 | 0.44 | 0.43 |
Support 2 (S2) | 0.43 | 0.43 | 0.43 | 0.43 | |
Support 3 (S3) | 0.42 | 0.43 | 0.43 | ||
Support 4 (S4) | 0.42 |